CDMO Profile

CHA Biotech

CHA Biotech Contract Manufacturing & Development (CDMO) Profile

ì°¸ ì¢‹ì€ ë³‘ì›, ì°¨ë³‘ì› ì¸ê°„ì¡´ì¤‘, ìƒëª…ì‚¬ëž‘ì„ ì‹¤ì²œí•˜ëŠ” ì—°êµ¬ì¤‘ì‹¬ì˜ ê¸€ë¡œë²Œ ì¢…í•©ë³‘ì›ìž…ë‹ˆë‹¤. ì´ˆì¼ë¥˜ ê¸€ë¡œë²Œ ìƒëª…ê³µí•™ê·¸ë£¹ ì‹¤í˜„ì„ í•¨ê»˜í•©ë‹ˆë‹¤ ì°¸ ì¢‹ì€ ë³‘ì› , ì°¨ë³‘ì› ëŒ€í•œë¯¼êµ NO.1 ë°”ì´ì˜¤í—¬ìŠ¤ì¼€ì–´ê·¸ë£¹ COPYRIGHT@2023 CHAMC. ALL RIGHTS RESERVED

CDMO Services:
Cell & Gene Therapy Sterile Vials Cell Line Development; Formulation Development Live Viral Vaccines; Viral Vector Vaccines; Plasmid DNA; Live Biotherapeutic Products

Year Founded: 1960

Head Office: , Korea, Republic of

Number of Facilities: 6-10

Facility locations: North America; East Asia

Website: Visit the CHA Biotech website

Linkedin: Connect on Linkedin

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing. Register here

July 22, 2024
CDMO, CHA Biotech
CDMO Guide

SURVEY

Benchmark your Outsourcing Strategies for 2025

DOWNLOAD

5 Digital Strategies for Decentralised Clinical Trials

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.